Physician profile
Mitchell Everett Daugherty
NPI 1417481540
$753.48
in general payments reported to CMS, 2019-2025
15 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $330 · 2023: $93.10 · 2024: $18.94 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.07 | 2021-2022 | |
| Welch Allyn | $124.57 | 2021 | |
| Radius Health, INC. | $121.12 | 2025 | Tymlos |
| Stryker Corporation | $62.95 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $57.61 | 2021-2022 | |
| Pfizer INC. | $44.94 | 2023 | |
| Novo Nordisk INC | $38.13 | 2022 | |
| Crossroads Orthopedics, LLC | $34.41 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.13 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.64 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.28 | 2022 | |
| Bioventus LLC | $20.39 | 2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $18.94 | 2024 | Physio-Stim |
| Depuy Synthes Sales INC. | $13.75 | 2023 | Orthovisc, Monovisc |
| Merck Sharp & Dohme LLC | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Daugherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.